FDA ANDA · ANDA218248
HYDROCHLOROTHIAZIDE
Sponsor: RUBICON RESEARCH
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA218248
TYPE
ANDA
ORIGINAL APPROVAL
2026-10-07
LATEST ACTION
2026-10-07
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
HYDROCHLOROTHIAZIDEPrescription
HYDROCHLOROTHIAZIDE 50MG/5ML · SOLUTION · ORAL
Approval history
2026-10-07UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →